Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on January 8, 2021, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), Medical CBRN Defense Consortium (“MCDC”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Aldevron, LLC, Fargo, ND; Applied Nanotech, Inc., Austin, TX; Clark Street Associates, Los Altos, CA; Encryptor, Inc., Plano, TX; Entasis Therapeutics, Waltham, MA; ImmunityBio, Inc., El Segundo, CA; Polaris Sensor Technologies, Huntsville, AL; Qorvo Biotechnologies, LLC, Bend, OR; Rigel Pharmaceuticals, San Francisco, CA; SafetySpect, Inc., Los Angeles, CA; and Somnio Global, LLC, Novi, MI have been added as parties to this venture.                

Also, 7 Hills Pharma, LLC, Houston, TX; ARMSTEL, Inc., Plano, TX; Captura Biopharma, Inc., Little Rock, AR; Chenega Reliable Services, LLC, San Antonio, TX; Data Intelligence Technologies, Inc., Arlington, VA; DEFTEC Corporation, Huntsville, AL; HDT Bio Corporation, Seattle, WA; MAE Group, LLC, Deerfield, NH; Metabiota, Inc., San Francisco, CA; Microscale Devices, LLC, Apex, NC; One Health Group, LLC, Chantilly, VA; Pathology Assist-Temp, Inc., Chantilly, VA; Peregrine Technical Solutions, LLC, Yorktown, VA; Profectus BioSciences, Inc., Baltimore, MD; TensorX, Inc., Vienna, VA and the University of Michigan, Ann Arbor, MI have withdrawn as parties to this venture.

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership.

                    On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513).                

                    The last notification was filed with the Department on October 20, 2020. A notice was published in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on November 20, 2020 (85 FR 74386).                

Suzanne Morris, 

Chief, Premerger and Division Statistics, Antitrust Division.

[FR Doc. 2021-01051 Filed 1-15-21; 8:45 am]

BILLING CODE P